BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8639425)

  • 1. The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia.
    Dias-Da-Motta P; Arruda VR; Muscará MN; Saad ST; De Nucci G; Costa FF; Condino-Neto A
    Br J Haematol; 1996 May; 93(2):333-40. PubMed ID: 8639425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophils and mononuclear cells from patients with chronic granulomatous disease release nitric oxide.
    Condino-Neto A; Muscará MN; Grumach AS; Carneiro-Sampaio MM; De Nucci G
    Br J Clin Pharmacol; 1993 May; 35(5):485-90. PubMed ID: 8390277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nitric oxide formation in vivo enhances superoxide release by the perfused liver.
    Bautista AP; Spitzer JJ
    Am J Physiol; 1994 May; 266(5 Pt 1):G783-8. PubMed ID: 8203525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor.
    Salvemini D; de Nucci G; Gryglewski RJ; Vane JR
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6328-32. PubMed ID: 2548208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion.
    McCall TB; Boughton-Smith NK; Palmer RM; Whittle BJ; Moncada S
    Biochem J; 1989 Jul; 261(1):293-6. PubMed ID: 2549965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function.
    De Miguel LS; Jiménez A; Montón M; Farré J; Del Mar Arriero M; Rodríguez-Feo JA; García-Cañete J; Rico L; Gómez J; Núñez A; Casado S; Farré AL
    Eur J Clin Invest; 2000 Sep; 30(9):811-7. PubMed ID: 10998082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of nitric oxide in lipoxin A4-induced polymorphonuclear neutrophil-dependent cytotoxicity to human vascular endothelium in vitro.
    Bratt J; Gyllenhammar H
    Arthritis Rheum; 1995 Jun; 38(6):768-76. PubMed ID: 7779119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation.
    Laffi G; Foschi M; Masini E; Simoni A; Mugnai L; La Villa G; Barletta G; Mannaioni PF; Gentilini P
    Hepatology; 1995 Dec; 22(6):1666-73. PubMed ID: 7489972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro.
    Faint RW; Mackie IJ; Machin SJ
    Br J Haematol; 1991 Apr; 77(4):539-45. PubMed ID: 1851034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the L-arginine:nitric oxide pathway in human platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol.
    Mehta JL; Lopez LM; Chen L; Cox OE
    Am J Cardiol; 1994 Nov; 74(9):901-5. PubMed ID: 7526676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-induced peroxynitrite production from endothelial cells.
    Kooy NW; Royall JA
    Arch Biochem Biophys; 1994 May; 310(2):352-9. PubMed ID: 8179319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the production of nitric oxide and superoxide by inflammatory cells in liver cirrhosis.
    Masini E; Mugnai L; Foschi M; Laffi G; Gentilini P; Mannaioni PF
    Int Arch Allergy Immunol; 1995; 107(1-3):197-8. PubMed ID: 7613130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditions to study nitric oxide generation by polymorphonuclear cells from an inflammatory exudate in rats.
    Ródenas J; Carbonell T; Mitjavila MT
    Arch Biochem Biophys; 1996 Mar; 327(2):292-4. PubMed ID: 8619617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of nitric oxide by human neutrophils.
    Wright CD; Mülsch A; Busse R; Osswald H
    Biochem Biophys Res Commun; 1989 Apr; 160(2):813-9. PubMed ID: 2541713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes.
    Pieper GM; Clarke GA; Gross GJ
    J Pharmacol Exp Ther; 1994 May; 269(2):451-6. PubMed ID: 8182511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that nitric oxide is an endogenous antiangiogenic mediator.
    Pipili-Synetos E; Sakkoula E; Haralabopoulos G; Andriopoulou P; Peristeris P; Maragoudakis ME
    Br J Pharmacol; 1994 Mar; 111(3):894-902. PubMed ID: 7517330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism.
    Broekman MJ; Eiroa AM; Marcus AJ
    Blood; 1991 Aug; 78(4):1033-40. PubMed ID: 1868238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultured astrocytoma cells inhibit platelet aggregation by releasing a nitric oxide-like factor.
    Mollace V; Salvemini D; Anggård E; Vane J
    Biochem Biophys Res Commun; 1990 Oct; 172(2):564-9. PubMed ID: 2241954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nitric oxide-dependent inhibition of platelet aggregation in elderly patients with hypercholesterolemia].
    Ueda S; Katagiri M; Matsumoto Y; Nishimura T; Matsushita S; Mori M; Ozawa T; Orimo H
    Nihon Ronen Igakkai Zasshi; 2001 Mar; 38(2):177-84. PubMed ID: 11305031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.